Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein-2 Without Decortication of Osseous Elements
- 1 June 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Spine
- Vol. 22 (11) , 1171-1180
- https://doi.org/10.1097/00007632-199706010-00001
Abstract
L4-L5 intertransverse process fusions were produced with 58 μg, 230 μg, or 920 μg of recombinant human bone morphogenetic protein-2 in 20 dogs. Eleven had traditional decortication of posterior elements before insertion of the implant. Nine were left undecorticated. All animals were evaluated 3 months after surgery. To determine whether decortication is a prerequisite for successful fusion in the presence of osteoinductive proteins such as bone morphogenetic protein-2. Recombinant osteoinductive proteins can induce de novo bone in ectopic soft-tissue sites in the absence of bone marrow elements. Traditional methods for achieving spinal fusion rely on exposure of bone marrow through decortication to facilitate osteogenesis. It is hypothesized that the presence of an implanted osteoinductive protein obviates the need for exposure and release of host inductive factors. Recombinant human bone morphogenetic protein-2-induced intertransverse process fusions were performed with and without decortication. Fusion sites were evaluated by computed tomography imaging, high-resolution radiography, manual testing, mechanical testing, and histologic analysis. One hundred percent of decorticated spines and 89% of undecorticated spines were clinically fused by 3 months. Ninety-one percent of decorticated spines and 78% of undecorticated specimens exhibited bilateral transverse process osseous bridging. The only spines that failed to achieve solid bilateral arthrodesis were in the lowest dose group. With the higher two doses, there was histologic evidence of osseous continuity between the fusion mass and undecorticated transverse processes. There were no statistical differences in clinical and radiographic fusion rates between decorticated and undecorticated sites. With higher doses of recombinant human bone morphogenetic protein-2, there was little histologic distinction between fusions in decorticated versus undecorticated spines.Keywords
This publication has 11 references indexed in Scilit:
- Evaluation of rhBMP-2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion ModelSpine, 1995
- Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein-2Spine, 1995
- Is It Necessary to Decorticate Segmentally Instrumented Spines to Achieve Fusion?Spine, 1994
- Iliac Crest Versus Spinous Process Grafts in Posttraumatic Spinal FusionsSpine, 1992
- Recombinant human bone morphogenetic protein induces bone formation.Proceedings of the National Academy of Sciences, 1990
- Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a collagenous delivery vehicleJournal of Biomedical Materials Research, 1989
- Purification and characterization of other distinct bone-inducing factors.Proceedings of the National Academy of Sciences, 1988
- Solubilized and insolubilized bone morphogenetic protein.Proceedings of the National Academy of Sciences, 1979
- HETEROTOPIC TRANSPLANTS OF BONE MARROWTransplantation, 1968
- Bone: Formation by AutoinductionScience, 1965